RapheGenerics was founded in 2005 and acquired by USABachem Corporation in 2025. It is the center of excellence for the Americas organization in the development of new peptide chemical entities (NCEs), with in-depth knowledge and expertise in chemistry, manufacturing, and controls (CMC) to achieve successful commercialization. Together with state-of-the-art equipment and a rapidly growing degree of automation, the Garland site delivers efficient over-the-counter drug products and research-grade peptide active pharmaceutical ingredients (API) on a small to medium scale.

We make Pharmaceutical chemistry and generic peptide API research scale products. Our specialty is in protected amino acids, Semaglutide, Retatrutide, Sermorelin, Tirzepatide, TB-500, BPC-157 Salt Arginate, AOD9604, Ipamorelin, Epitalon, Glutathione, Cagrillintide, and MOTS-C, available in customized forms such as injectables, Sublinguals, and Long-acting tablets.

Transdermal drug delivery system and self-care OTC.